Crinetics Pharmaceuticals (NasdaqGS:CRNX) FY Earnings Call Presentation
2026-01-13 17:45
JANUARY 2026 Beyond Innovation to Impact: Building the Premier Endocrinology Business J.P. Morgan Healthcare Conference Angela Living with Acromegaly Forward Looking Statements and Legal Disclaimers Forward Looking Statements: This presentation contains forward-looking statements. Crinetics Pharmaceuticals, Inc. ("Crinetics," the "company," "we," "us," or "our") cautions you that all statements other than statements of historical facts contained in this presentation are forward-looking statements. Such forw ...
Revvity (NYSE:RVTY) FY Earnings Call Presentation
2026-01-13 17:45
J.P. Morgan 44th Healthcare Conference Prahlad Singh Chief Executive Officer January 13, 2026 Safe Harbor This presentation contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to the Company's customers and end-markets, plans concerning business development oppo ...
Novo Nordisk (NYSE:NVO) FY Earnings Call Presentation
2026-01-13 17:45
Novo Nordisk – a focused healthcare company JP Morgan Healthcare conference 2 J.P. Morgan Healthcare conference Forward-looking statements Novo Nordisk's statutory Annual Report, 2024. Form 20-F, any quarterly financial reports, imvestor gresentations and wiriten information released, shown, or oral satements future by or on behalf of Moro Nordisk, may contain certain forward-looking statements relating to the operating. Ifrancial and sustainability coeformance and results of No rindustry in which it operat ...
Kymera Therapeutics (NasdaqGM:KYMR) FY Earnings Call Presentation
2026-01-13 17:00
Revolutionizing Immunology with Oral Medicines Nello Mainolfi, PhD, Founder, President & CEO Kymera Therapeutics J.P. Morgan Healthcare Conference | January 2026 Patient-first mentality, with urgency: Rapidly advancing first-in-industry oral degraders with biologics-like activity Forward Looking Statements Defining and surpassing clinical benchmarks: Demonstrated compelling clinical translation of degraders' impact on clinical endpoints This presentation contains forward-looking statements within the meanin ...
Agilent Technologies (NYSE:A) FY Earnings Call Presentation
2026-01-13 17:00
Agilent Technologies Padraig McDonnell, President & CEO J.P. Morgan Healthcare Conference January 13, 2026 2026 J.P. Morgan Healthcare Conference Safe harbor This presentation contains forward-looking statements (including, without limitation, statements on Agilent's (the "company" or "our") strategy, priorities, growth and growth opportunities, productivity, reinvestment, customer focus, evolving product mix, work environment and innovation plans; the effects of the Ignite Operating System; the size and gr ...
Cardinal Health (NYSE:CAH) FY Earnings Call Presentation
2026-01-13 17:00
Continuing our multi-year growth journey © 2026 Cardinal Health. All Rights Reserved. 1 © 2026 Cardinal Health. All Rights Reserved. JP MORGAN CONFERENCE Cautions Concerning Forward-Looking Statements This presentation contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would ...
Viatris (NasdaqGS:VTRS) FY Earnings Call Presentation
2026-01-13 17:00
44th Annual J.P. Morgan Healthcare Conference January 13, 2026 1 Non-GAAP Financial Measures This presentation includes the presentation and discussion of certain financial information that differs from what is reported under accounting principles generally accepted in the United States ("U.S. GAAP"). These non-GAAP financial measures, including, but not limited to, adjusted EBITDA, free cash flow, free cash flow excluding transaction-related costs, and adjusted EPS, are presented in order to supplement inv ...
Ionis Pharmaceuticals (NasdaqGS:IONS) FY Earnings Call Presentation
2026-01-13 16:15
44th Annual J.P. Morgan Healthcare Conference 2026 Breakthrough Therapies Driving Accelerating Growth Brett Monia, Ph.D. Chief Executive Officer January 2026 | Nasdaq: IONS Forward-Looking Statements This presentation includes forward-looking statements regarding our business, financial guidance and the therapeutic and commercial potential of our commercial medicines, additional medicines in development and technologies and our expectations regarding development and regulatory milestones. Any statement desc ...
Edgewise Therapeutics (NasdaqGS:EWTX) FY Earnings Call Presentation
2026-01-13 16:15
Forward Looking Statement This presentation contains contains forward-looking statements as that term is defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this presentation that are not purely historical are forward-looking statements. Such forward-looking statements include, among other things, statements regarding the potential of, and expectations regarding, Edgewise's product candidates and programs, including sevasemten, EDG-7500, ...
Thermo Fisher Scientific (NYSE:TMO) FY Earnings Call Presentation
2026-01-13 16:15
J.P. Morgan Healthcare Conference January 13, 2026 Marc N. Casper Chairman, President and Chief Executive Officer The world leader in serving science Various remarks that we may make in the following presentation about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995, including statements about future revenue and financial results. Forward-looking statements are b ...